Ian T. Meredith

Insider Reports History

Location
Marlborough, MA
Signature
/s/ Susan Thompson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ian T. Meredith:

Company Role Class Num Shares Value Price $ Report Date Ownership
BOSTON SCIENTIFIC CORP EVP Global Chief Med Officer Common Stock 28,082 $1,684,920 $60.00 28 Mar 2022 Direct
BOSTON SCIENTIFIC CORP EVP Global Chief Med Officer Performance Share Units 6,540 $378,077 $57.81 22 Feb 2022 Direct
BOSTON SCIENTIFIC CORP EVP Global Chief Med Officer Stock Option (Right to Buy) 12,941 $224,785 $17.37 16 Feb 2022 Direct
BOSTON SCIENTIFIC CORP EVP Global Chief Med Officer Restricted Stock Units 3,750 $202,725 $54.06 17 Feb 2022 Direct
BOSTON SCIENTIFIC CORP EVP Global Chief Med Officer Deferred Stock Units 0 $54.06 28 Feb 2022 Direct

Insider Reports Filed by Ian T. Meredith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BSX BOSTON SCIENTIFIC CORP 28 Mar 2022 1 -$287,764 4 EVP Global Chief Med Officer 29 Mar 2022, 16:45
BSX BOSTON SCIENTIFIC CORP 28 Feb 2022 3 -$13,251 4 EVP Global Chief Med Officer 02 Mar 2022, 15:27
BSX BOSTON SCIENTIFIC CORP 22 Feb 2022 1 $0 4 EVP Global Chief Med Officer 24 Feb 2022, 15:21
BSX BOSTON SCIENTIFIC CORP 21 Feb 2022 3 -$12,680 4 EVP Global Chief Med Officer 23 Feb 2022, 15:16
BSX BOSTON SCIENTIFIC CORP 17 Feb 2022 6 -$28,696 4 EVP Global Chief Med Officer 22 Feb 2022, 15:45
BSX BOSTON SCIENTIFIC CORP 15 Feb 2022 5 -$14,347 4 EVP Global Chief Med Officer 17 Feb 2022, 19:21
BSX BOSTON SCIENTIFIC CORP 01 Feb 2022 3 -$39,976 4 EVP Global Chief Med Officer 02 Feb 2022, 15:37
BSX BOSTON SCIENTIFIC CORP 01 Jan 2022 3 -$53,737 4 EVP Global Chief Med Officer 03 Jan 2022, 15:51
BSX BOSTON SCIENTIFIC CORP 28 Dec 2021 1 -$303,248 4 EVP Global Chief Med Officer 29 Dec 2021, 15:33